Is Credo Technology a Buy, Sell, or Hold Ahead of Q2 Earnings Release?

Credo Technology (CRDO) is set to report fiscal Q2 results on Dec. 1, 2025; Zacks consensus pegs EPS at $0.49 (≈600% YoY) and revenues at $235.2M (≈226.6% YoY), while company guidance is $230–$240M (midpoint up ~5% QoQ) with expected non‑GAAP gross margins of 64–66% and opex $56–58M. Fiscal Q1 outperformed at $223.1M revenue (↑31% QoQ, ↑274% YoY) and product revenue $217.1M (↑279% YoY), driven by AEC and optical demand from hyperscalers; strengths include SerDes/IP and optical DSP ramps, but risks include heavy customer concentration, fierce competition (Broadcom, Marvell), tariff/macro uncertainty and a premium forward P/E (~96.6x) that underpin Zacks' cautious Hold stance.

Analysis

Market structure: Credo (CRDO) is a direct beneficiary of near-term AI hyperscaler capex — AEC and optical DSP demand is tightening high‑speed interconnect supply and supports premium pricing and >60% non‑GAAP gross margins in the near term. Incumbents (AVGO, MRVL) face displacement risk on bespoke SerDes/retimer requirements but retain pricing/scale advantages that can pressure smaller players once ramps slow. Expect 1–2 quarters of pricing/volume power for specialized interconnect suppliers while commodity component suppliers (copper, standard optics) see only modest uplift.

Risk assessment: Tail risks include a single hyperscaler pullback (>20% order reduction, plausible within 3–6 months) or tariff-driven cost shocks reducing gross margin by 300–800bps. Immediately (days) earnings/guide will drive volatility; short term (weeks–months) customer ramps determine revenue; long term (2026+) competition and fab/CM capacity determine sustainable margins. Hidden dependency: concentration on top 3 customers (>10% each) and single-source CM/fab exposure can instantaneously cut revenue by >25%.

Trade implications: Tactical exposure to CRDO should be sized small (1–3% portfolio) and structured with options to limit downside; favor call‑spread for upside and protective puts for equity holdings around earnings. Consider pair trades (long MRVL vs short CRDO) to express a mean‑reversion of valuation dispersion if hyperscaler spend normalizes by H2 2026. Rotate modestly into larger-scale AI infrastructure winners (AVGO) for balance.

Contrarian angles: Consensus underestimates non‑linear downside from customer concentration and overestimates durable pricing power implied in a ~97x forward P/E; a 30–40% re‑rating is plausible if one large customer pauses. Historical parallel: small networking ASIC vendors have seen swift margin compression when incumbents integrated functions (Mellanox→NVDA style exceptions exist), so outcome depends on design‑win stickiness — track multi‑year design‑win confirmation, not single‑quarter revenue.

Key Decisions for Investors

• Establish a tactical long in CRDO sized 2% of portfolio on a 3–7% pullback from current levels; place stop‑loss at -12% and an upside take‑profit at +50% or if FY26 revenue growth <+40% or non‑GAAP gross margin guidance falls below 62% on release (time horizon 6–12 months).
• If capital constrained, buy a Feb‑2026 CRDO call spread (buy ATM, sell 25% OTM) sized to 1% portfolio exposure; close after the next two quarterly reports or if implied volatility compresses >30% from pre‑earnings peak.
• Implement a relative‑value pair: long MRVL (2% of portfolio) / short CRDO (1.5%) to capture valuation convergence if hyperscaler spending normalizes by H2 2026; enter if CRDO forward P/E >90 and/or MRVL trades down >10%; rebalance quarterly.
• Limit total exposure to hyperscaler‑concentrated names to max 6% of portfolio; if any single CRDO customer is disclosed at >25% of revenue or if CRDO guidance misses revenue by >5%, trim CRDO position by 50% and buy short‑dated protective puts (30–60 days).